Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component

American Journal of Hematology

Volumn 83, Issue 3, 2008, Pages 218-221

  Yang, David T ^a   Dunphy, Cherie H ^b   Tripp, Sheryl R ^c   Lagoo, Anand S ^d   Perkins, Sherrie L ^a,c,e  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CHILD; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; CHILD; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 39749181615     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21077     Document Type: Article

References (23)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyons, France: IARC Press; 2001.
2. Braeuninger A, Kuppers R, Strickler JG, et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci USA 1997;94:9337-9342.
3. Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997;337:453-458.
4. Diehl V, Sextro M, Franklin J, et al. Clinical presentation, course, and prognostic factors in lymphocyte predominant Hodgkin's disease and lymphocyte-rich classical Hodgkins disease: Report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 1999;17:776-783.
5. Regula D, Hoppe R, Weiss L. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988;318:214-220.
6. Mauch P, Kalish L, Kadin M, et al. Patterns of presentation of Hodgkin's disease. Cancer 1993;71:2062-2071.
7. Borg-Grech A, Radford J, Crowther D, et al. A comparative study of the nodular and diffuse variants of lymphocyte predominant Hodgkin's disease. J Clin Oncol 1989;7:1303-1309.
8. Miettinen M, Fransilla KO, Saxen E. Hodgkin's disease, lymphocyte predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer 1983;51:2293-2300.
9. Sundeen JT Cossman J, Jaffe ES. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histologic progression or composite malignancy? Am J Surg Pathol 1988;15:599-606.
10. Hansmann ML, Stein H, Fellbaum C, et al. Nodular paraganglioma can transform into high-grade malignant lymphoma of B type. Hum Pathol 1989;20:1169-1175.
11. Wickert RS, Weisenburger DD, Tierens A, et al. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large cell lymphoma of B lineage. Blood 1995;86:2312-2320.
12. Greiner TC, Gascoyne RD, Anderson ME, et al. Nodular lymphocyte predominant Hodgkin's disease associated with large-cell lymphoma: Analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood 1996;88:657-666.
13. Ohno T, Huang JZ, Wu G, et al. The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis. Am J Clin Pathol 2001;116:506-511.
14. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966;26:1063-1081.
15. Fan Z, Natkunam Y, Bair E, et al. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 2003;27:1346-1356.
16. Boudova L, Torlakovic E, Delabie J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 2003; 102:3753-3758.
17. Sup SJ, Alemany CA, Pohlman B, et al. Expression of bcl-2 in classical Hodgkin's lymphoma: An independent predictor of poor outcome. J Clin Oncol 2005;23:3773-3779.
18. Uherova P, Valdez R, Ross CW, et al. Nodular lymphocyte predominant Hodgkin lymphoma: An immunophenotypic reappraisal based on a single-institution experience. Am J Clin Pathol 2003;119:192-198.
19. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N Engl J Med 1984;311:1471-1475.
20. Lo Coco F, Gaidano G, Louie DC, et al. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993;82:2289-2295.
21. Lossos IS, Alizadeh AA, Diehn M, et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with Increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99:8886-8891.
22. Elenitoba-Johnson KS, Gascoyne RD, Lim MS, et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998;91:4677-4685.
23. Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood 2000;96:635-639.